Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC-Reference-Cited by-同舟云学术

Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC

Published:2024-08-09 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Tosello Valeria,Grassi Angela,Rose Dominic,Bao Loc Carlo,Zulato Elisabetta,Dalle Fratte Chiara,Polano Maurizio,Del Bianco Paola,Pasello Giulia,Guarneri Valentina,Indraccolo Stefano,Bonanno Laura

Funder

Istituto Oncologico Veneto

Ministero della Salute

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-68229-6.pdf

Reference42 articles.

1. Mosele, F. et al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group. Ann. Oncol. 31, 1491–1505. https://doi.org/10.1016/j.annonc.2020.07.014 (2020).

2. Nikanjam, M., Kato, S. & Kurzrock, R. Liquid biopsy: Current technology and clinical applications. J. Hematol. Oncol. 15, 131. https://doi.org/10.1186/s13045-022-01351-y (2022).

3. Rolfo, C. et al. Liquid biopsy for advanced NSCLC: A consensus statement from the international association for the study of lung cancer. J. Thorac. Oncol. 16, 1647–1662. https://doi.org/10.1016/j.jtho.2021.06.017 (2021).

4. Bonanno, L. et al. Liquid biopsy and non-small cell lung cancer: Are we looking at the tip of the iceberg?. Br. J. Cancer 127, 383–393. https://doi.org/10.1038/s41416-022-01777-8 (2022).

5. Tissot, C. et al. Circulating free DNA concentration is an independent prognostic biomarker in lung cancer. Eur. Respir. J. 46, 1773–1780. https://doi.org/10.1183/13993003.00676-2015 (2015).